MARKET

AMPE

AMPE

AMPIO PHARMA
AMEX

Real-time Quotes | Nasdaq Last Sale

0.3633
+0.0106
+3.01%
Closed 16:00 11/12 EST
OPEN
0.3550
PREV CLOSE
0.3527
HIGH
0.3700
LOW
0.3500
VOLUME
243.29K
TURNOVER
--
52 WEEK HIGH
1.310
52 WEEK LOW
0.2600
MARKET CAP
57.64M
P/E (TTM)
5.39
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AMPE and other stocks commission-free!

Open a Webull account and fund it to get a free stock

EPS

AMPE News

  • Ampio execs subpoenaed over alleged insider trading
  • Seeking Alpha - Article.5d ago
  • Ampio Provides Update on Continued Progress of AP-013 Phase III Clinical Trial and Manufacturing Facility
  • PR Newswire.10/10 13:30
  • Ampio Pharma Offers Update On Continued Progress Of AP-013 Phase 3 Trial, Manufacturing Facility
  • Benzinga.10/10 12:35
  • Ampio Retains Legal Counsel for Transaction Advisory Committee
  • PR Newswire.09/18 13:30

More

Industry

Biotechnology & Medical Research
+0.28%
Pharmaceuticals & Medical Research
+0.27%

Hot Stocks

Name
Price
%Change

About AMPE

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The Company's two lead product candidates in development are Ampion for osteoarthritis of the knee and Optina for diabetic macular edema. Ampion is a sub 5000 molecular weight fraction of commercial human serum albumin (HSA). Optina is a low-dose formulation of danazol. The Ampio segment consists of its biopharmaceuticals compounds and the clinical trials associated with them. The Company is primarily developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process, and decreasing vascular permeability.
More

Webull offers Ampio Pharmaceuticals Inc (AMPE) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.